Brain and Acute Leukemia, Cytoplasmic (BAALC) Peptid

Details zu Produkt Nr. ABIN369346, Anbieter: Anmelden zum Anzeigen
Proteinname
  • si:zc215i13.3
  • si:ch211-215i13.3
  • BAALC
  • 2810457D07Rik
  • brain and acute leukemia, cytoplasmic
  • BAALC
  • baalc
  • Baalc
Spezies
Human, Maus, Ratte (Rattus), Schwein
Quelle
Synthetic
Methodentyp
Peptide ELISA
Applikation
Immunogen (Imm)
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Geblockter Antikörper anti-BAALC Antikörper (Brain and Acute Leukemia, Cytoplasmic) (Internal Region) (ABIN334357)
Sequenz KQNGLQTTEA KRDAK
Produktmerkmale The peptide was used in the production of ABIN369346 - Goat Anti-BAALC Antibody. It is currently untested in blocking applications.
Applikationshinweise When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Lyophilized
Lagerung -20 °C
Informationen zur Lagerung Shipped at ambient temperature, store at -20°C
Bilder des Herstellers
Western Blotting (WB) image for Brain and Acute Leukemia, Cytoplasmic (BAALC) peptide (ABIN369346) Brain and Acute Leukemia, Cytoplasmic (BAALC) peptide
Western Blotting (WB) image for Brain and Acute Leukemia, Cytoplasmic (BAALC) peptide (ABIN369346) Brain and Acute Leukemia, Cytoplasmic (BAALC) peptide (Image 2)